5paisa Capital: consolidated PAT falls 26% YoY to ₹7.06 Cr as margins compress
PAT -25.55% YoY · revenue +11.79% · margins compressing
₹86.42 Cr
+11.79% YoY
₹7.06 Cr
-25.55% YoY
8.16%
-4.1pp YoY
₹1.55
5paisa Capital's consolidated profit after tax fell 25.6% year-on-year to ₹7.06 Cr in Q2 FY27 (from ₹9.48 Cr in Q2 FY26), even as revenue from operations grew 11.8% YoY to ₹86.42 Cr (from ₹77.30 Cr). Sequentially both lines declined — revenue 2.2% and PAT 39% versus Q1 FY27's ₹88.33 Cr revenue and ₹11.57 Cr PAT — but the YoY comparison is the one that matters here: profit growth trailed revenue growth by a wide margin, net profit margin compressed to 8.2% from 12.3% a year ago (13.1% last quarter), and EBITDA margin fell to roughly 25.3% from roughly 29.7% YoY. Basic EPS was ₹1.55, down from ₹3.04 in Q2 FY26 and ₹2.60 in Q1 FY27. Standalone (parent-only) PAT was near-identical at ₹7.02 Cr on ₹86.42 Cr revenue, confirming the four wholly-owned subsidiaries (P2P, Trading, Corporate Services, IFSC) contribute little to group earnings.
Q2 FY-2027 vs prior quarters
The squeeze sits on finance cost and depreciation rather than the core broking cost line: finance cost rose 18.5% YoY to ₹9.45 Cr and depreciation/amortisation climbed 22% YoY to ₹2.91 Cr, while employee costs grew a more moderate 7.5% YoY to ₹22.05 Cr. No exceptional items were booked in either period, so the YoY PAT decline is fully organic — there is no one-off to adjust for and no separate adjusted-growth figure is needed.
The stock went into the print at ₹344.15, up 9.9% over the past month of trading.
No quantitative forward targets. Strategic deployment of ₹468 Cr capital: ₹227 Cr exchange margin (RBI mandate), ₹150 Cr debt repayment, ₹88 Cr product/tech/marketing. Next 12 months: user engagement, adoption, monetization from platform upgrades; adjacent expansion organic/inorganic.
— This quarter: met
There is no tracked consensus estimate for this print — a web search turned up only a pre-result preview carrying reported comparatives with no analyst PAT estimate, so vsStreet is unknown. Management's only prior guidance (Q1 FY27 concall, cautiously-optimistic tone, no quantitative targets) was a qualitative plan to deploy the ₹468.82 Cr rights-issue proceeds: ₹227 Cr toward an RBI-mandated exchange margin, ₹150 Cr toward debt repayment, ₹88 Cr toward product/tech/marketing. The balance sheet shows real progress on the debt leg — borrowings fell to ₹213.73 Cr from ₹304.32 Cr at FY26-end, a ₹90.6 Cr H1 reduction, roughly 60% of the full-year target with two quarters still to run — so the company is tracking that guidance even as the cost of the broader strategy (higher finance cost, capex-driven depreciation) shows up in this quarter's P&L. No separate press release accompanied this filing, so there is no additional management commentary to reconcile against beyond the notes to the results. Concurrently, the board is progressing the Giskard Datatech acquisition (a 19.76% stake already picked up for ₹40.95 Cr cash, full buyout approved July 28, 2026, funded via a share-swap preferential issue updated October 9, 2026), CTO Ameya Agnihotri resigned (September 30, 2026), and the company separately received a ₹15.31 Cr GST show-cause notice (October 1, 2026) — distinct from the ₹33.02 Cr income-tax demand disclosed in this filing (a block-period FY19-25 search assessment, now under CIT(A) appeal; auditors issued an unmodified opinion with an emphasis of matter on it).
W1
Whether finance cost (₹9.45 Cr this quarter, +18.5% YoY) eases as the remaining ~₹59 Cr of the planned ₹150 Cr debt repayment is completed.
W2
Progress on the Giskard Datatech acquisition (board-approved July 28, 2026; 19.76% stake already acquired for ₹40.95 Cr) and its effect on consolidation once completed.
W3
Outcome of the CIT(A) appeal against the ₹33.02 Cr income-tax demand.
App rebuild underway, but margin collapse signals execution risk
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
No prior numeric guidance to track; Q2 delivered ₹86.5 Cr revenue and ₹7.1 Cr PAT as reported; margin compression unaddressed
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
5paisa is executing a credible long-term product rebuild (new app, AI, balance sheet at ₹1,136 Cr) but near-term execution is unproven and PAT has collapsed 26% YoY despite 12% revenue growth, signaling aggressive margin compression. Without quantified medium-term targets or proof of product traction, the risk/reward is balanced.
₹86.5 Cr
Revenue · +11.8% YoY₹7.1 Cr
Reported PAT · −25.5% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
New app with AI features driving engagement
UnverifiedFeatures live for weeks/months only; AI engagement unquantified; too early to assess user impact
95% of customers open accounts DIY
METAligns with stated digital-first strategy; demonstrates product appeal
Soft quarter due to derivatives volume drop
METAverage daily turnover ₹2.59T reflects market-wide slowdown; legitimate external headwind
Best years still ahead
OVERSTATEDNo quantified roadmap; PAT down 26% YoY; depends entirely on unproven app/AI/Trendlyne execution
Earnings quality
What changed since the last call
Balance sheet strengthened materially
UpgradeNet worth jumped from ₹650 Cr (Mar 2026) to ₹1,136 Cr post-rights issue; funding book now ₹480 Cr (safe spread); MF AUM ₹2,095 Cr
Product roadmap aggressive
UpgradeNew app with AI, algo trading (AlgoSpace), Xstreme APIs, co-location, Trendlyne acquisition, IPO feature planned — material expansion vs prior call's vague 'product upgrades'
Near-term profitability deteriorated
DowngradePAT declined 39% QoQ and 25.5% YoY despite 11.8% revenue growth; attributed to investment spend + market softness but severity not quantified in prior call
The Q&A
Minimal. Only one analyst (Daksh Prashar, Desvelado) asked substantive questions on Trendlyne integration and AI engagement. Management gave evasive, non-committal answers ('too early day', 'will see how it pans out'). No pushback on PAT collapse or margin trajectory.
Trendlyne acquisition integration — Daksh Prashar, Desvelado
PartialBoard approved July, formal closure pending. Will decide on legal structure post-close. Plan is to bring Trendlyne's baskets, screeners, AI stack into 5paisa app.
AI engagement and retention — Daksh Prashar, Desvelado
DodgedToo early, features live only weeks/months. If product gives real value, engagement tends to rise. Mutual fund 'Ask 5paisa' feature tested but unclear if it drives trade volume yet.
Guidance
No quantified FY27 revenue target
LowManagement stated focus on 'user engagement, adoption, monetization' but refused numeric guidance. Prior call also had no targets.
No margin guidance disclosed
LowQ2 saw material margin compression (PAT -25.5% YoY); management cited investment spend + soft market but provided no forward margin outlook.
₹88 Cr allocated to product/tech/marketing from ₹468 Cr capital deployment
Medium₹62M capitalized in Q2 for app build; expected to continue but no quarterly breakdown. Total capex envelope unclear.
Risks the call surfaced
Product execution
HighNew app, AI assistant, Trendlyne acquisition all in early stages (features live weeks/months only). Engagement metrics not disclosed. Management admitted 'too early' to assess impact.
Margin compression
HighPAT fell 25.5% YoY (₹7.1 Cr) and 39% QoQ despite 11.8% revenue growth. Attributed to capex and soft market, but severity and duration unclear. OPM 25.2%, NPM 8.2% — both declining YoY if PAT down more than revenue.
Market headwinds
MediumManagement noted derivatives volumes dropped after cash rollout; active NSE clients at ~46 million. Attributes to cyclical market downturn, not structural. If slowdown persists, revenue growth at risk.
Acquisition integration
MediumBoard approved Trendlyne acquisition end-July; formal closure still pending. Unclear whether Trendlyne will remain subsidiary or be fully merged. Product synergies claimed but not quantified.
No quantified guidance
LowManagement explicitly avoided numeric revenue/margin/growth targets. Stated focus on 'user engagement, adoption, monetization' but no milestones. Hard to track execution or validate long-term claims.
Management
Score 6/10. Clear on vision and product roadmap but evasive on near-term metrics (PAT decline downplayed, AI engagement unquantified). Declined to provide forward guidance. Capital allocation credible (₹1,136 Cr balance sheet, ₹150 Cr debt repayment); product investments ongoing but early-stage impact unproven. No history of missed targets because none have been stated.
1 · H2 FY27
Trendlyne acquisition closure and product integration into 5paisa app
2 · Near future
IPO-related feature launch announced but not detailed
3 · Ongoing
AI engagement metrics (Ask 5paisa, portfolio analysis) to demonstrate user retention gains
Without quantified medium-term targets or proof of product traction, the risk/reward is balanced.
Revenue Up, Profits Down 26%—Execution Risk on the App Bet
5paisa delivered 12% revenue growth but PAT collapsed 26% YoY, signaling aggressive investment spend and soft market conditions. The quarter's real story is whether the app rebuild, AI features, and Trendlyne acquisition can drive margin recovery—or if near-term profitability remains under pressure.
₹86.5 Cr
+11.8% YoY, customer growth +81.6K
₹7.1 Cr
-25.5% YoY, -39% QoQ
25.2%
Compressed by capex + soft market
₹1,136 Cr net worth
+₹486 Cr from rights issue
The headline read is a paradox: revenue up 12%, net profit down 26%. The gap reveals where 5paisa's money went this quarter and the stakes of what comes next.
Why profit fell despite revenue growth
PAT declined ₹4.5 Cr quarter-on-quarter (39% drop) and ₹2.6 Cr year-on-year (26% decline) while revenue grew. Management attributed the squeeze to two factors: heavy product investment spend (app development, AI features, Trendlyne integration prep) and soft derivatives market post-cash rollout. The company capitalized ₹62 million in app development costs in Q2 alone, which will amortize forward and pressure margins for "several years," though no schedule was disclosed. This choice—to invest aggressively while market headwinds blow—signals confidence in the product roadmap but leaves near-term profitability vulnerable.
Management claims vs. what holds up
New app with AI features driving engagement
UnverifiedAsk 5paisa and AI portfolio tools live for only weeks to a few months. Management admitted 'it is a little early day.' Engagement metrics and user retention gains not disclosed.
95% of customers open accounts DIY
SupportedAligns with stated digital-first strategy and 53.4L customer base with 81.6K new adds this quarter. Demonstrates product appeal.
Soft quarter due to derivatives volume drop
SupportedDerivatives volumes post-cash rollout were cyclical market headwind. Average daily NSE turnover ₹2.59T reflects industry-wide slowdown, not 5paisa-specific operational issue.
Best years still ahead
OverstatedNo quantified forward targets. PAT down 26% YoY. Product roadmap ambitious (new app, AI, Trendlyne, AlgoSpace) but execution unproven and timelines vague. Depends entirely on speculative product bets.
What changed on this call
Balance sheet upgraded materially: Net worth jumped ₹486 Cr post-rights issue (from ₹650 Cr in Mar 2026 to ₹1,136 Cr now), enabling debt repayment (₹150 Cr planned) and product investment (₹88 Cr envelope). Funding book at ₹480 Cr average with safe spreads.
Product roadmap expanded with specificity: Rebuilt app with new OMS/RMS, AI assistant (Ask 5paisa), algo trading (AlgoSpace), Xstreme APIs, co-location, and Trendlyne acquisition (board approved end-July, formal closure pending). Material upgrade from prior call's vague 'product upgrades.'
Near-term profitability deteriorated sharply: PAT down 39% QoQ and 25.5% YoY despite 11.8% revenue growth. Severity and expected recovery timeline not addressed in prior call or disclosed now.
No quantified guidance, again: Management reiterated its refusal to provide revenue, margin, or growth targets. Focus stated as 'user engagement, adoption, monetization' but no milestones. Makes accountability difficult.
The bull-bear ledger
Balance sheet now fortress-like: ₹1,136 Cr net worth funds 3+ years of aggressive product investment without dilution or debt.
Customer growth steady: 81.6K new accounts this quarter, 53.4L total, with 95% DIY signup rate proving product-led traction.
Product roadmap credible in scope: New app, AI, algo trading, Trendlyne research moat, co-location—diversification away from vanilla broking.
PAT collapse unaddressed: Down 26% YoY despite 12% revenue growth. No margin recovery plan or timeline disclosed. Capex amortization drag to persist years.
Execution risk very high: New features (app, AI, Trendlyne) live only weeks to months. Engagement metrics withheld. Management framed product viability as 'too early to assess.'
Market headwinds cyclical but persistent: Derivatives volumes soft post-cash rollout. No clarity on demand recovery timeline or whether slowdown masks product weakness.
Trendlyne integration path unclear: Board approved end-July; formal closure still pending. Whether it merges, stays subsidiary, or how synergies materialize—all deferred.
Risks, ranked by how much they should concern a holder
Product execution fails or takes longer than expected
HIGHNew app, AI, Trendlyne are the only margin recovery bets. If adoption is slow, engagement doesn't materialize, or integration stumbles, near-term margin pressure persists and long-term thesis breaks. Currently unquantified and unproven (features days/weeks old).
PAT continues to decline while investments continue
HIGHIf Q3/Q4 see further PAT declines without visibility to product monetization, confidence will crack. Management has no margin targets to defend against; quarterly P&L becomes the only scorecard.
Derivatives slowdown is structural, not cyclical
MEDIUMUnderlying assumption is that cash rollout downturn is temporary and retail participation will recover. If derivatives volumes remain suppressed, revenue growth headwind persists and capex ROI timeline extends.
Trendlyne closure delayed further or integration disappoints
MEDIUMStill pending formal close. Delays would postpone revenue synergy and proof-of-concept for M&A strategy. Weak integration would undermine confidence in adjacent expansion.
Competitive intensity rises on product quality
MEDIUMDiscount broking space crowded (Zerodha, Shoonya, others). 5paisa's app/AI differentiation must hold or margin recovery narrative fails. No moat proof yet.
How the street is positioned
Price action: The day-1 move was muted: +0.25% to ₹344.4, barely holding the pre-result close of ₹344.15. Minimal conviction either way. The market's restraint makes sense—revenue growth is real, but profit collapse invites caution on near-term execution. Stock now sits at ₹325, below the 20/50/200-day SMAs (331.61/345.76/336.38), suggesting it's lost momentum post-result.
Valuation context: The stock is down 57.19% from its all-time high of ₹759.1, but up 32.65% from the 52-week low (₹245). It sits roughly at the 200-day MA level, not deeply cheap but not bouncing either. RSI at 43.1 is neutral—no oversold capitulation, no overbought euphoria.
Institutional flows: FII ownership rose from 12.41% (Q4 FY26) to 15.11% (Q1 FY27), a +2.7pp gain—meaningful buying during the quarters bracketing this result. Promoters also bought, increasing stake from 32.77% to 36.50% (+3.73pp). DII remained near zero. The insider and FII buying signals confidence in the long-term bet, but the muted day-1 price reaction shows the street isn't rushing to chase it.
The institution positioning and insider buying do not contradict the fundamental read of execution risk—they align with a high-risk, high-reward thesis. FII and promoters are betting on the product roadmap panning out. But the stock's technical weakness (below key SMAs) and minimal post-result pop suggest most of the market is skeptical or waiting for proof.
The debate
1 · Q3 PAT and margin trajectory
Is the decline stabilizing or accelerating? Does PAT reach ₹7–₹8 Cr range (steady state) or drop further? Monitor the quarterly amortization schedule—if capex continues at ₹50–₹100M/Q, margins stay depressed. Management must quantify the recovery timeline, not just say 'wait and see.'
2 · Trendlyne formal closure and integration announcements
When does the acquisition close? Does it merge into the 5paisa app or remain separate? What are the early user engagement and cross-sell metrics? Any synergy quantification (revenue uplift, cost savings, customer lifetime value gains)? This will tell whether the deal is a strategic win or a distraction.
3 · New app and AI feature adoption metrics
Management said features are 'only weeks to months old'—Q3/Q4 should show early traction signals. Monitor: monthly active users on the new app, Ask 5paisa engagement (daily active users, queries answered, conversion to trade), customer acquisition cost (CAC), and retention cohorts. If these metrics are silent, it's a warning sign.
5paisa had a steady quarter—not a step-change. Revenue grew 12%, but profit fell 26%, and the company chose to invest instead of defend margins. That's a credible strategic choice given a fortress balance sheet, but it's also an admission that near-term earnings will be messy. The long-term bet on product, AI, and Trendlyne is sound; the near-term proof is absent.
For holders, the game is one of patience: expect continued pressure on PAT through H2 FY27, and demand that management quantify margin recovery timelines and product adoption milestones in the next call. For new entrants, wait for proof that the app and AI are driving user retention and monetization; ₹325 is fairly priced at current execution risk.
The number to track from here is organic net profit (PAT minus any one-time items), not revenue. If capex-driven PAT decline persists into Q4 without visibility to margin recovery, confidence will erode, and the stock will re-test the ₹250–₹270 range.